Q4 2024 Earnings Conference Call February 11, 2025 5:00 PM ETCompany ParticipantsAlex Brown – Director, Investor ...
Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and ...
U.S. Food and Drug Administration (FDA) recently accepted the Biologics License Application (BLA) for RP1 plus nivolumab in advanced melanoma for ...
Gladstone Capital Corporation's (NASDAQ:GLAD) earnings call for the fourth quarter of 2025 highlighted a mix of strategic growth and financial adjustments. The company reported a decline in total ...